2020
DOI: 10.1016/j.biopha.2020.110721
|View full text |Cite
|
Sign up to set email alerts
|

New understanding of the pathogenesis and treatment of stroke-related sarcopenia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
48
0
2

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 68 publications
(51 citation statements)
references
References 79 publications
1
48
0
2
Order By: Relevance
“…In addition, sarcopenia caused by aging further reduces muscle strength, limiting the activities of daily life and resulting in decreased HRQOL. [35][36][37][38][39] In addition, social interaction decreases and psychological conditions such as depression worsen with age, which further adversely affects HRQOL. 19) Among the factors examined in this study, the controllable factors were smoking, alcohol intake, and walking.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, sarcopenia caused by aging further reduces muscle strength, limiting the activities of daily life and resulting in decreased HRQOL. [35][36][37][38][39] In addition, social interaction decreases and psychological conditions such as depression worsen with age, which further adversely affects HRQOL. 19) Among the factors examined in this study, the controllable factors were smoking, alcohol intake, and walking.…”
Section: Discussionmentioning
confidence: 99%
“…In healthy people, muscle tissue is gradually lost during aging, resulting in a decrease in mass and strength, a condition described as sarcopenia ( 8 ). In specific pathological conditions, especially in those that may invoke inflammatory processes, disease-related immobility or malnutrition, sarcopenia can occur as secondary, defining a “specific sarcopenia” ( 6 ). Recently, the muscle atrophy, consequent to the stroke has been defined as a new condition called “stroke-induced sarcopenia” or “stroke-related sarcopenia”; it has also been associated with worse clinical outcomes and physical dysfunction ( 6 , 9 ).…”
Section: Morphological Changesmentioning
confidence: 99%
“…Traditionally, the rehabilitation effort has been oriented toward the treatment of the central nervous system (CNS) damage with a central approach, which exploits the plastic capacity of the neural cells to recover the best motor control. In this paradigm, muscle tissue is often overlooked ( 6 ). In our opinion, to ensure greater effectiveness of rehabilitation, new protocol approaches are needed, focused on muscle modifications over time.…”
Section: Introductionmentioning
confidence: 99%
“…In recent years, more attention has been given to research about the modifications in the characteristics of the muscle tissue after a stroke [ 8 ]. In this context, stroke-related sarcopenia is characterized by a rapid decline in muscle mass after onset, muscle fiber-type shifts, determining bilateral differences in the physical and functional performance of brain lesions, impaired feeding and complex systemic metabolic changes [ 7 , 9 ]. Stroke-related sarcopenia has been described in a variety of settings, with a prevalence of 16.8% in the community [ 10 ] and 48.3–60.3% in the convalescent rehabilitation ward [ 11 , 12 ].…”
Section: Introductionmentioning
confidence: 99%